1 completed, 1 unknown, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Nodding Syndrome: new trials by email Literature Review of Nodding Syndrome trials Research Report on Nodding Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012 Pyridoxine, Sodium Valproate, Phenytoin - Nodding Syndrome | Phase 2 | Withdrawn | Centers for Disease Control and Prevention | 2016-02-01 | 2022-05-18 | |
| Clinical Features and Potential Etiology of Epilepsy and Nodding Syndrome in the Mahenge Area, Ulanga District no intervention - Nodding Syndrome, Epilepsy | Unknown | Heidelberg University | 250 | 2014-10-01 | 2018-08-31 | |
| Catatonia in Nodding Syndrome and Lorazepam Treatment Lorazepam - Catatonia, Nodding Syndrome | Phase 1 | Completed | Makerere University | 16 | 2013-03-01 | 2015-06-03 |
Catatonia (1) · Cognitive Dysfunction (1) · Epilepsy (1) · Onchocerciasis (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Epilepsy, Generalized (3) · Nervous System Diseases (3) · Epilepsy (2) · Behavior (1) · Behavioral Symptoms (1) · Cognition Disorders (1) · Filariasis (1) · Helminthiasis (1) · Infections (1) · Mental Disorders (1) · Nematode Infections (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1)
Lorazepam (1) · Phenytoin (1) · Pyridoxine (1) · Valproic Acid (1) · Vitamin B 6 (1)
Centers for Disease Control and Prevention (1) · Heidelberg University (1) · Makerere University (1)
Tanzania (1) · Uganda (1)
Angelina Kakooza-Mwesige, MMed (1) · Dirk M Dhossche, MD, PhD (1) · Scott Dowell, MD (1)